Elevated f-fdg uptake in skeletal muscles and thymus: a clue for the diagnosis of graves' disease

Nuclear Medicine Communications

Volumn 25, Issue 2, 2004, Pages 115-121

  Chen, Yen Kung ^a   Chen, Yen Ling ^b   Liao, Alfred C ^b   Shen, Yeh You ^c   Kao, Chia Hung ^c  

^a Departments of Nuclear Medicine   (United States)

^b SHIN KONG WU HO SU MEMORIAL HOSPITAL   (Taiwan)

^c CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

FDG; Graves' disease; PET; Skeletal muscle; Thymus hyperplasia

Indexed keywords

DIAGNOSTIC AGENT; FLUORODEOXYGLUCOSE F 18; RADIOPHARMACEUTICAL AGENT;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; GLUCOSE BLOOD LEVEL; GRAVES DISEASE; HUMAN; MALE; METABOLISM; MIDDLE AGED; SCINTISCANNING; SKELETAL MUSCLE; THYMUS; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG UPTAKE; GLUCOSE UTILIZATION; POSITRON EMISSION TOMOGRAPHY; PSOAS MUSCLE; RECTUS ABDOMINIS MUSCLE; THYROID FUNCTION; THYROID GLAND;

ADULT; AGED; BLOOD GLUCOSE; FEMALE; FLUORODEOXYGLUCOSE F18; GRAVES DISEASE; HUMANS; MALE; MIDDLE AGED; MUSCLE, SKELETAL; RADIOPHARMACEUTICALS; THYMUS GLAND; TOMOGRAPHY, EMISSION-COMPUTED; TOMOGRAPHY, X-RAY COMPUTED;

EID: 1542284698     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/00006231-200402000-00004     Document Type: Article

References (22)

1. Rapoport B, Chazenbalk GD, Jaume JC, McLachlan SM. The thyrotropin (TSH) receptor: interaction with TSH and autoantibodies. Endocr Rev 1998; 19:673-716.
2. Spaulding SW. Age and the thyroid. Endocrinol Metab Clin North Am 1987; 16:1013-1025.
3. Boerner AR, Voth E, Theissen P, Wienhard K, Wagner R, Schicha H. Glucose metabolism of the thyroid in Graves' disease measured by F-18-fluoro-deoxyglucose positron emission tomography. Thyroid 1998; 8:765-772.
4. Halsted WS. Significance of the thymus gland in Graves' disease. Bull John Hopkins Hosp 1914; 25:223-234.
5. Michie W, Beck JS, Mahaffy RG, Honein EF, Fowler GB. Quantitative radiological and histological studies of the thymus in thyroid disease. Lancet 1967; i:691-695.
6. Gunn A, Michie W, Irvine WJ. The thymus in thyroid disease. Lancet 1964; ii:776-778.
7. McAllister RM, Sansone Jr JC, Laughlin MH. Effects of hyperthyroidism on muscle blood flow during exercise in rats. Am J Physiology 1995; 268:H330-H335.
8. Weinstein SP, Watts J, Haber RS. Thyroid hormone increases muscle/fat glucose transporter gene expression in rat skeletal muscle. Endocrinology 1991; 129:455-464.
9. Casla A, Rovira A, Wells JA, Dohm GL. Increased glucose transporter (GLUT4) protein expression in hyperthyroidism. Biochem Biophys Res Comm 1990; 171:182-188.
10. Dimitriadis G, Parry-Billings M, Bevan S, Leighton B, Krause U, Piva T, et al. The effects of insulin on transport and metabolism of glucose in skeletal muscle from hyperthyroid and hypothyroid rats. Eur J Clin Invest 1997; 27:475-483.
11. Sugden MC, Lall HS, Harris RA, Holness MJ. Selective modification of the pyruvate dehydrogenase kinase isoform profile in skeletal muscle in hyperthyroidism: implications for the regulatory impact of glucose on fatty acid oxidation. J Endocrinol 2000; 167:339-345.
12. Kelley DE, Williams KV, Price JC. Insulin regulation of glucose transport and phosphoration in skeletal muscle assessed by PET. Am J Physiol 1999; 277:E361-E369.
13. Huitink JM, Visser FC, van Leeuwen GR, van Lingen A, Bax JJ, Heine RJ, et al. Influence of high and low plasma insulin levels on the uptake of fluorine-18 fluorodeoxyglucose in myocardium and femoral muscle, assessed by planar imaging. Eur J Nucl Med 1995; 22:1141-1148.
14. Foss MC, Paccola GMGF, Saad MJA, Pimenta WP, Piccinato CE, Iazigi N, et al. Peripheral glucose metabolism in human hyperthyroidism. J Clin Endocrinol Metab 1990; 70:1167-1172.
15. Dardenne M, Pleau JM, Nabarra B, et al. Contribution of zinc and other metals to the biological activity of the serum thymic factor. Proc Natl Acad Sci USA 1982; 79:5370-5373.
16. Bach JF, Papiernik M, Levasseur P, Dardenne M, Barois A, Le Brigand H, et al. Evidence for a serum-factor secreted by the human thymus. Lancet 1972; 2:1056-1058.
17. Fabris N, Mocchegiani E, Provinciali M. Plasticity of neuro-endocrine-thymus interactions during aging - a minireview. Cell Mol Biol 1997; 43:529-541.
18. Fabris N, Mocchegiani E, Mariotti S, Pacini F, Pinchera A. Thyroid function modulates thymic endocrine activity. J Clin Endocrinol Metab 1986; 62:474-478.
19. Murakami M, Hosoi Y, Negishi T, Kamiya Y, Miyashita K, Yamada M, et al. Thymic hyperplasia in patients with Graves' disease. Identification of thyrotropin receptors in human thymus. J Clin Invest 1996; 98:2228-2234.
20. 18F-FDG PET: age dependency and frequency after chemotherapy. J Nucl Med 2001; 42:591-595.
21. Yasuda S, Shohtsu A, Ide M, Takagi S, Takahashi W, Suzuki Y, Horiuchi M. Chronic thyroiditis: diffuse uptake of FDG at PET. Radiology 1998; 207:775-778.
22. Field JB. Intermediary metabolism of the thyroid. In: Greep RO, Astwood EB, editors. Handbook of Physiology Endocrinology, III. Washington: American Physiology Society; 1974. pp. 147-159.